continues to support multinational neurological treatment protocols using the Esperanza NeuroPeptide. The current NeuroPeptide program focuses primarily on patients presenting with Multiple Sclerosis (MS). These treatment protocols do not use placebos. The purpose of these investigations is to evaluate a new, once a day, sublingual homeopathic preparation (sprayed under the tongue) that replaces injectable dosage formats currently used by most MS patients. Patients commit to the treatment/study for a minimum of a year with clinic evaluations and a minimum half-year for non clinic evaluation.

Esperanza Peptide offers five treatment prices (6-month, 9-month, 12-month, 18-month and 24-month). First, we offer subsidised, 12-month, 18-month and 24-month treatments and NeuroPeptide supply, that costs the participating patients in the UK and Europe the following £6,750 (UK) for 12-months, £9,990 for 18-months and £11,880 for 24-months. In the USA, Canada and the Rest Of The World the prices are $12,500 (USA) for 12-months, $17,000 for 18-months and $24,000 for 24-month.

Second, we offer 6-month and 9-month treatment time frames for those that want to try the Esperanza NeuroPeptide treatment before fully committing to the full-year,18-month or 24-month treatment and supply. The 6-month and 9-month treatment and supply prices are without clinics, are not subsidised and are delivered to the patient via courier with full dosing instructions. The cost for these non-subsidised 6-month and 9-month treatments and supplies are £5,450 (UK) for a 9-month supply and £4,000 for a 6-month supply. In the USA, Canada and the Rest Of The World the cost for 9-month is $10,000 (USA) and 6-month is $7,500. Again, the 6-month and 9-month treatment and supply (unlike the 12-month, 18-month and 24-month treatment price) is not subsidised and does not include clinic visit and workups.

The 12-month, 18-month and 24-month costs include all of the clinical assessments, dosing analysis, and consultations with our Practitioners and clinic team, as well as one year's supply of the Esperanza Peptide Homeopathic Sublingual Spray.

Once accepted into the open multinational treatment program, patients can choose either clinic evaluation or delivery of the NeuroPeptide with dosing instructions. If the patient chooses to attend a clinic there are over 100 clinic locations worldwide. (for list of available clinics click here). Patients are tested and evaluated for upper body function, lower body function, balance, speech and cognitive function. The initial testing, evaluation, dosing and retesting takes approximately three to four hours. Some of the tests and evaluations are video taped. Patients are monitored, re-evaluated and re-tested at various points throughout the treatment period for protocols at the various clinics worldwide click here. Each patient is responsible for their own transportation, to and from the clinics. Families, friends and significant others are welcome and encouraged to accompany the patient to the clinics.

Many patients regain function and experience fewer and less severe MS exacerbations. We do not believe this treatment is a cure. It is much like insulin is to a diabetic. It only works if it is taken daily. There is often measurable improvement in speech, pain, strength, balance and motor function in the first few days. Patients often continue to improve and usually plateau between year one and year three (every patient is unique and as such results and timeframes vary significantly). The goal of these treatments is to statistically evaluate any and all changes that provide MS patients with an improved quality of life.

To read a more definitive report on expectations and possible results after your Esperanza NeuroPeptide treatment click here.

The Sublingual Homeopathic spray (Esperanza Homeopathic NeuroPeptide) contains a peptide (71 amino acid chain) at a concentration of 10ug/ml. The daily dose is 6ug. The sublingual preparation is non-toxic, and in studies to date, these preparations have exhibited no adverse side effects.

IF YOU ARE INTERESTED IN PROGRESSING AND GETTING FURTHER INFORMATION CLICK HERE.

IF YOU WISH TO BOOK A CLINIC APPOINTMENT FOR TREATMENT AT A CLINIC NEAR YOU CLICK HERE.

IF YOU ARE INTERESTED IN VIEWING AVAILABLE CLINICS WORLDWIDE CLICK HERE.

IF YOU WISH TO REVIEW THE ESPERANZA PRICING FOR TREATMENTS CLICK HERE.

CLINICAL TRIAL PROGRAM

Esperanza Peptide plans to conduct ongoing trials with both humans and animals. In humans, the first application of these unique peptides will be the treatment of Multiple Sclerosis (MS).

It is believed that our unique peptide product could supersede interferon-based treatments whose sales currently generate over $2 billion per annum. With over 3 million MS patients globally requiring medication specifically for their condition, our unique peptide supplement efficacy and cost will guarantee significant market penetration.

CLINICAL TRIAL FUNDING

To date, funds have been spent on the evaluation of the new and cutting edge Esperanza Homeopathic NeuroPeptide sublingual spray into preliminary clinical trials. We are in the process of raising $15 million in order to continue and expand these trials.

We expect much of this funding will come via donations from various philanthropic organisations, corporate and private donations. Any interested individual, group, association or organisation can contact us by filling out our contact information form.

Our focus is to proceed to human clinical trials in the U.K. and Canada as soon as $10 million is available. This sum is expected to cover the initial cost of the clinical evaluation and chronic toxicity / reproductive studies required for approval.

Once phase two trials have been successful, we will then be in a position to bring a proven and fully documented drug to the attention of major pharmaceutical companies (known as "Big Pharma") in a format that lets them purchase rights. Such a licensing agreement with "Big Pharma is expected to bring significant amounts of funding to help us move forward with our various projects. This is an exciting time for Esperanza Peptide as we embark upon partnership with "Big Pharma" and the expansion of our pipeline of drug products and remedies to combat diseases and serious medical conditions worldwide!

Thank you for studying this information; if we can be of any further assistance, please do not hesitate to contact us.